Efficacy and safety of omalizumab in chronic rhinosinusitis with nasal polyps: a systematic review and meta-analysis of randomised controlled trials
Guardado en:
Autores principales: | Lianxiong Yuan, Xuekun Huang, Rui Zheng, Huijun Qiu, Xinyue Wang |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
BMJ Publishing Group
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/6934bd89d64b4e2a9a31401895c97bea |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
NASAL MUCOUS MEMBRANE MICROFLORA IN PATIENTS WITH POLYPOUS RHINOSINUSITIS
por: O. A. Kolenchukova, et al.
Publicado: (2017) -
Vimentin Expression in Nasal Mucosa of Patients with Exacerbated Chronic Rhinosinusitis Without Nasal Polyps
por: Onishchenko A. I., et al.
Publicado: (2019) -
CHARACTERISTICS OF CELLULAR IMMUNE STATUS IN THE PATIENTS WITH CHRONIC RHINOSINUSITIS WITH NASAL POLYPS
por: E. L. Savlevich, et al.
Publicado: (2017) -
Effect of Obstructive Sleep Apnea on Immunity in Cases of Chronic Rhinosinusitis With Nasal Polyps
por: Dong-Kyu Kim, et al.
Publicado: (2021) -
A global analysis of tandem 3'UTRs in eosinophilic chronic rhinosinusitis with nasal polyps.
por: Peng Tian, et al.
Publicado: (2012)